Testing Our Testing: Assessing HIV and STD Screening Coverage (i.e., We’ve just gone meta.)

8:30 AM

D6.1

Identifying Gaps and Best Practices for HIV/STI Screenings Using Nationally Standardized Data in the Indian Health Service Electronic Health Record (EHR)

Scott Tulloch, BS, NCHHSTP, DSTDP, OD, Centers for Disease Contorl and Prevention, Albuquerque, NM, Brigg Reilley, MPH, National HIV/AIDS Progam, Indian Health Serive, Albuquerque, NM and MELANIE Taylor, MD, MPH, DIVISION OF STD PREVENTION, CENTERS FOR DISEASE CONTROL, Phoenix, AZ

8:40 AM

D6.2

Variable Chlamydia Screening Coverage Estimates Derived Through Healthcare Effectiveness Data and Information System (HEDIS) Procedures and Indirect Estimation

Jennifer Broad, MPH, Department of Epidemiology, University of Washington-Seattle, Seattle, WA, Roxanne Kerani, PhD, HIV/STD Control Program, Public Health - Seattle and King County, Seattle, WA, Lisa E. Manhart, MPH, PHD, Department of Epidemiology and Cetner for AIDS and STD, University of Washington, Seattle, WA, Delia Scholes, PhD, Group Health Research Institute, Group Health Cooperative, Seattle, WA, James Hughes, PhD, Biostatitics, University of Washington, Seattle, WA and Matthew Golden, MD, MPH, Center for AIDS and STD, University of Washington, Seattle, WA

8:50 AM

D6.3

Comparing Two Methods of Estimating Chlamydia Screening Coverage in An Urban Neighborhood, 2009

Melissa Kyriakos Nelson, MSc, Cicatelli Associates Inc, New York, NY, Preeti Pathela, PhD, Bureau of STD Control and Prevention, The New York City Department of Health and Mental Hygiene, Long Island City, NY, Susan Blank, MD, MPH, Bureau of STD Control and Prevention, NYC Department of Health & Mental Hygiene, Long Island City, NY and Julia Schillinger, MD, MSc, US Centers for Disease Control and Prevention, CDC Division of STD Prevention;, NYC DOHMH Bureau of STD,The New York City Department of Health and Mental Hygiene;, New York, NY

9:00 AM

D6.4

Self-Reported Chlamydia Testing of Women in the United States, 2006-2008

Karen W. Hoover, MD, MPH, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, Guoyu Tao, PhD, Division of STD Prevention; Health Services Research and Evaluation Branch, CDC, Atlanta, GA, Jami Leichliter, PhD, CDC, Division of STD Prevention, Atlanta, GA and Thomas A. Peterman, MD, MSc, Epidemiology and Surveillance Branch, Centers for Disease Control and Prevention, Atlanta, GA

9:10 AM

D6.5

Using Regional Prevalence Monitoring Data to Evaluate Chlamydia Rescreening and Reinfection Rates At Infertility Prevention Project (IPP) Screening Sites

Charlie Rabins, MPH, Health Care Education and Training, Carmel, IN and Shana Cash, MPH, CHES, Health Care Education & Training, Inc, Carmel, IN

9:20 AM

D6.6

Overutilization of Chlamydia Testing by Privately Insured Women Aged 26-44 Years in 2008

Guoyu Tao, PhD, Division of STD Prevention; Health Services Research and Evaluation Branch, CDC, Atlanta, GA and Karen W. Hoover, MD, MPH, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA

D6 Testing Our Testing: Assessing HIV and STD Screening Coverage (i.e., We’ve just gone meta.)